chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea, Enterovirus test negative, Eosinophil percentage, Fatigue
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Human metapneumovirus test, Human rhinovirus test, Hypoxia
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza A virus test negative, Influenza virus test negative, Lung opacity, Lymphocyte percentage decreased, Mental status changes
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Monocyte percentage increased, Mycoplasma test negative, Neutrophil percentage increased, Orthopnoea, Platelet count normal
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Protein total normal, Pulmonary oedema, Respirovirus test, Sinus disorder, Somnolence
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin I normal, White blood cell count normal, White matter lesion
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: GUILLAIN-BARRE SYNDROME; PASSED OUT; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 35 year old female of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included thrombocytopenia, and concurrent conditions included congestive heart failure, hypertension, diabetes type 2, atrial fibrillation, and sustained ventricular tachycardia, and patient had no known allergies. Patient had no current illnesses at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, 1 total administered on the left arm 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 02-APR-2021, the patient started to get lethargic. Two weeks into the shot, it was getting hard to walk and he started falling at work. The patient was out of work for a week, and couldn't get up by himself anymore, and he had to get a cane. On 28-APR-2021, he went to the doctor again with no results. On 01-MAY-2021, the patient passed out and was not able to get up. On 02-MAY-2021, the patient went to the emergency room and had a spinal tap and was diagnosed with Guillain-Barre Syndrome (also conflictingly reported as developing Guillain-Barre Syndrome on 07-MAY-2021). The patient was hospitalized from 02-MAY-2021 to 07-MAY-2021 (also conflictingly reported as hospitalized for 6 days).    The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passed out and had not recovered from Guillain-Barre Syndrome (unable to get up, unable to walk, stumbling, pain, could not get up, started falling, falling at work, lethargic). This report was serious (Hospitalization Caused / Prolonged and Other Medically Important Condition).; Sender's Comments: V0 : 20210520943- COVID-19 VACCINE AD26.COV2.S - Guillain-Barre Syndrome, Passed out. This events are considered unassessable. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Feeling abnormal, Gait disturbance, General physical health deterioration, Guillain-Barre syndrome
Clinical narrative: GUILLAIN-BARRE SYNDROME; PASSED OUT; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 35 year old female of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included thrombocytopenia, and concurrent conditions included congestive heart failure, hypertension, diabetes type 2, atrial fibrillation, and sustained ventricular tachycardia, and patient had no known allergies. Patient had no current illnesses at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, 1 total administered on the left arm 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 02-APR-2021, the patient started to get lethargic. Two weeks into the shot, it was getting hard to walk and he started falling at work. The patient was out of work for a week, and couldn't get up by himself anymore, and he had to get a cane. On 28-APR-2021, he went to the doctor again with no results. On 01-MAY-2021, the patient passed out and was not able to get up. On 02-MAY-2021, the patient went to the emergency room and had a spinal tap and was diagnosed with Guillain-Barre Syndrome (also conflictingly reported as developing Guillain-Barre Syndrome on 07-MAY-2021). The patient was hospitalized from 02-MAY-2021 to 07-MAY-2021 (also conflictingly reported as hospitalized for 6 days).    The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passed out and had not recovered from Guillain-Barre Syndrome (unable to get up, unable to walk, stumbling, pain, could not get up, started falling, falling at work, lethargic). This report was serious (Hospitalization Caused / Prolonged and Other Medically Important Condition).; Sender's Comments: V0 : 20210520943- COVID-19 VACCINE AD26.COV2.S - Guillain-Barre Syndrome, Passed out. This events are considered unassessable. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Lumbar puncture abnormal, Mobility decreased
Clinical narrative: GUILLAIN-BARRE SYNDROME; PASSED OUT; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 35 year old female of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included thrombocytopenia, and concurrent conditions included congestive heart failure, hypertension, diabetes type 2, atrial fibrillation, and sustained ventricular tachycardia, and patient had no known allergies. Patient had no current illnesses at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, 1 total administered on the left arm 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 02-APR-2021, the patient started to get lethargic. Two weeks into the shot, it was getting hard to walk and he started falling at work. The patient was out of work for a week, and couldn't get up by himself anymore, and he had to get a cane. On 28-APR-2021, he went to the doctor again with no results. On 01-MAY-2021, the patient passed out and was not able to get up. On 02-MAY-2021, the patient went to the emergency room and had a spinal tap and was diagnosed with Guillain-Barre Syndrome (also conflictingly reported as developing Guillain-Barre Syndrome on 07-MAY-2021). The patient was hospitalized from 02-MAY-2021 to 07-MAY-2021 (also conflictingly reported as hospitalized for 6 days).    The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passed out and had not recovered from Guillain-Barre Syndrome (unable to get up, unable to walk, stumbling, pain, could not get up, started falling, falling at work, lethargic). This report was serious (Hospitalization Caused / Prolonged and Other Medically Important Condition).; Sender's Comments: V0 : 20210520943- COVID-19 VACCINE AD26.COV2.S - Guillain-Barre Syndrome, Passed out. This events are considered unassessable. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Loss of consciousness, Lumbar puncture
Clinical narrative: GUILLAIN-BARRE SYNDROME; PASSED OUT; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 35 year old female of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included thrombocytopenia, and concurrent conditions included congestive heart failure, hypertension, diabetes type 2, atrial fibrillation, and sustained ventricular tachycardia, and patient had no known allergies. Patient had no current illnesses at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, 1 total administered on the left arm 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 02-APR-2021, the patient started to get lethargic. Two weeks into the shot, it was getting hard to walk and he started falling at work. The patient was out of work for a week, and couldn't get up by himself anymore, and he had to get a cane. On 28-APR-2021, he went to the doctor again with no results. On 01-MAY-2021, the patient passed out and was not able to get up. On 02-MAY-2021, the patient went to the emergency room and had a spinal tap and was diagnosed with Guillain-Barre Syndrome (also conflictingly reported as developing Guillain-Barre Syndrome on 07-MAY-2021). The patient was hospitalized from 02-MAY-2021 to 07-MAY-2021 (also conflictingly reported as hospitalized for 6 days).    The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passed out and had not recovered from Guillain-Barre Syndrome (unable to get up, unable to walk, stumbling, pain, could not get up, started falling, falling at work, lethargic). This report was serious (Hospitalization Caused / Prolonged and Other Medically Important Condition).; Sender's Comments: V0 : 20210520943- COVID-19 VACCINE AD26.COV2.S - Guillain-Barre Syndrome, Passed out. This events are considered unassessable. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Neuropathy peripheral, Paraesthesia
Clinical narrative: GUILLAIN-BARRE SYNDROME; PASSED OUT; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 35 year old female of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included thrombocytopenia, and concurrent conditions included congestive heart failure, hypertension, diabetes type 2, atrial fibrillation, and sustained ventricular tachycardia, and patient had no known allergies. Patient had no current illnesses at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, 1 total administered on the left arm 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 02-APR-2021, the patient started to get lethargic. Two weeks into the shot, it was getting hard to walk and he started falling at work. The patient was out of work for a week, and couldn't get up by himself anymore, and he had to get a cane. On 28-APR-2021, he went to the doctor again with no results. On 01-MAY-2021, the patient passed out and was not able to get up. On 02-MAY-2021, the patient went to the emergency room and had a spinal tap and was diagnosed with Guillain-Barre Syndrome (also conflictingly reported as developing Guillain-Barre Syndrome on 07-MAY-2021). The patient was hospitalized from 02-MAY-2021 to 07-MAY-2021 (also conflictingly reported as hospitalized for 6 days).    The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passed out and had not recovered from Guillain-Barre Syndrome (unable to get up, unable to walk, stumbling, pain, could not get up, started falling, falling at work, lethargic). This report was serious (Hospitalization Caused / Prolonged and Other Medically Important Condition).; Sender's Comments: V0 : 20210520943- COVID-19 VACCINE AD26.COV2.S - Guillain-Barre Syndrome, Passed out. This events are considered unassessable. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Depression, Gait disturbance, General physical health deterioration, Guillain-Barre syndrome, Myalgia
Clinical narrative: GUILLAIN-BARRE SYNDROME; PASSED OUT; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) concerned a 35 year old female of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included thrombocytopenia, and concurrent conditions included congestive heart failure, hypertension, diabetes type 2, atrial fibrillation, and sustained ventricular tachycardia, and patient had no known allergies. Patient had no current illnesses at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, 1 total administered on the left arm 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 02-APR-2021, the patient started to get lethargic. Two weeks into the shot, it was getting hard to walk and he started falling at work. The patient was out of work for a week, and couldn't get up by himself anymore, and he had to get a cane. On 28-APR-2021, he went to the doctor again with no results. On 01-MAY-2021, the patient passed out and was not able to get up. On 02-MAY-2021, the patient went to the emergency room and had a spinal tap and was diagnosed with Guillain-Barre Syndrome (also conflictingly reported as developing Guillain-Barre Syndrome on 07-MAY-2021). The patient was hospitalized from 02-MAY-2021 to 07-MAY-2021 (also conflictingly reported as hospitalized for 6 days).    The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passed out and had not recovered from Guillain-Barre Syndrome (unable to get up, unable to walk, stumbling, pain, could not get up, started falling, falling at work, lethargic). This report was serious (Hospitalization Caused / Prolonged and Other Medically Important Condition).; Sender's Comments: V0 : 20210520943- COVID-19 VACCINE AD26.COV2.S - Guillain-Barre Syndrome, Passed out. This events are considered unassessable. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood glucose increased, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Extreme fatigue, sluggishness and memory delays after the first vaccine. Worsened after the 2nd with confusion, forgetfulness, disorientation.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site bruising, Injection site mass, Injection site pain, Memory impairment, Metamorphopsia
Clinical narrative: Extreme fatigue, sluggishness and memory delays after the first vaccine. Worsened after the 2nd with confusion, forgetfulness, disorientation.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea
Clinical narrative: Extreme fatigue, sluggishness and memory delays after the first vaccine. Worsened after the 2nd with confusion, forgetfulness, disorientation.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Confusional state, Disorientation, Fatigue, Memory impairment
Clinical narrative: Extreme fatigue, sluggishness and memory delays after the first vaccine. Worsened after the 2nd with confusion, forgetfulness, disorientation.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sluggishness
Clinical narrative: Extreme fatigue, sluggishness and memory delays after the first vaccine. Worsened after the 2nd with confusion, forgetfulness, disorientation.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Back pain, Mobility decreased, Myalgia, Pain
Clinical narrative: sharp pains on my left shoulder; I can not make sudden movements; everyday things have become painful/ Im  in excruciating pain when I do it.; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received second dose of BNT162B2 (Pfizer COVID-19 Vaccine, Lot number: ER8733), via an unspecified route in left arm on 02Apr2021 as a single dose for covid-19 immunization. Medical history of the patient included allergies to soy, milk, peanuts and wheat. The patient's concomitant medications were not reported. Historical Vaccine included first dose of BNT162B2 (Pfizer COVID-19 Vaccine, Lot number: EN6206) in left arm on 12Mar2021 at 09:00 for Covid-19 immunization. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 09:00, patient experienced sharp pains on left shoulder, I cannot make sudden movements and everyday things have become painful. I can do everything I used to do with my left arm. I am in excruciating pain when I do it. Event resulted in Disability or permanent damage. Patient did not receive any treatment for the events. Device Date was 05May2021. The clinical outcome of the events was not recovered.  Follow-up (05May2021): New information received from the same contactable male consumer (patient) includes: Details of the first and second dose added, events onset date and time added, Allergies added, clinical outcome of events updated.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: sharp pains on my left shoulder; I can not make sudden movements; everyday things have become painful/ Im  in excruciating pain when I do it.; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received second dose of BNT162B2 (Pfizer COVID-19 Vaccine, Lot number: ER8733), via an unspecified route in left arm on 02Apr2021 as a single dose for covid-19 immunization. Medical history of the patient included allergies to soy, milk, peanuts and wheat. The patient's concomitant medications were not reported. Historical Vaccine included first dose of BNT162B2 (Pfizer COVID-19 Vaccine, Lot number: EN6206) in left arm on 12Mar2021 at 09:00 for Covid-19 immunization. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 09:00, patient experienced sharp pains on left shoulder, I cannot make sudden movements and everyday things have become painful. I can do everything I used to do with my left arm. I am in excruciating pain when I do it. Event resulted in Disability or permanent damage. Patient did not receive any treatment for the events. Device Date was 05May2021. The clinical outcome of the events was not recovered.  Follow-up (05May2021): New information received from the same contactable male consumer (patient) includes: Details of the first and second dose added, events onset date and time added, Allergies added, clinical outcome of events updated.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Movement disorder, Pain
Clinical narrative: sharp pains on my left shoulder; I can not make sudden movements; everyday things have become painful/ Im  in excruciating pain when I do it.; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received second dose of BNT162B2 (Pfizer COVID-19 Vaccine, Lot number: ER8733), via an unspecified route in left arm on 02Apr2021 as a single dose for covid-19 immunization. Medical history of the patient included allergies to soy, milk, peanuts and wheat. The patient's concomitant medications were not reported. Historical Vaccine included first dose of BNT162B2 (Pfizer COVID-19 Vaccine, Lot number: EN6206) in left arm on 12Mar2021 at 09:00 for Covid-19 immunization. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 09:00, patient experienced sharp pains on left shoulder, I cannot make sudden movements and everyday things have become painful. I can do everything I used to do with my left arm. I am in excruciating pain when I do it. Event resulted in Disability or permanent damage. Patient did not receive any treatment for the events. Device Date was 05May2021. The clinical outcome of the events was not recovered.  Follow-up (05May2021): New information received from the same contactable male consumer (patient) includes: Details of the first and second dose added, events onset date and time added, Allergies added, clinical outcome of events updated.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Blood calcium, Blood chloride normal, Blood creatinine normal, Blood potassium normal
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood sodium normal, Blood urea normal, COVID-19 pneumonia, Carbon dioxide normal, Haematocrit decreased
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin decreased, International normalised ratio normal, Platelet count normal, White blood cell count normal
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Adenovirus test, Angiogram pulmonary abnormal, Bordetella test negative, COVID-19 pneumonia
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Chills, Condition aggravated, Coronavirus test negative, Dyspnoea
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Enterovirus test negative, Fibrin D dimer increased, Hepatic steatosis, Human metapneumovirus test, Human rhinovirus test
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza A virus test negative, Influenza virus test negative, Lung infiltration, Lung opacity, Myalgia
Clinical narrative: Fever and chills  Myalgia  Viral syndrome  ED to Hosp-Admission Discharged  4/18/2021 - 4/22/2021 (4 days) Hospital  MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem  Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory failure with hypoxia (CMS/HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   Hospital Course     This pleasant 54-year-old gentleman with history of hypertension came in with increasing shortness of breath and hypoxia secondary to Covid pneumonia resulting in hypoxic respiratory failure and diffuse pulmonary infiltrates.  Patient was hospitalized for management of severe sepsis secondary to Covid pneumonia resulting in acute hypoxic respiratory failure.  Patient was also treated for possible secondary bacterial pneumonia given duration of Covid symptoms prior to coming into hospital.  Patient made nice recovery and was able to wean off from high flow oxygen down to 2 L with exertion.  Patient overall made nice recovery hence he was discharged home.   Patient was noted to have rising D-dimers despite clinical improvement in Covid infection.  He is at high risk for developing DVTs hence he was recommended to use Xarelto 10 mg daily for 1 month to prevent any risk of DVTs.   Patient voiced understanding of this.  In he was discharged home with home health care.   His readmission potential is low to moderate.